VX18-445-106


Study Name Study Title Study Type Sponsor Sponsor Type
VX18-445-106 A Phase 3 Study Evaluating the Pharmacokinetics, Safety, and Tolerability of VX-445/TEZ/IVA Triple Combination Therapy in Cystic Fibrosis Subjects 6 Through 11 Years of Age. Clinical Trial Vertex Industry Sponsored